Matches in Wikidata for { <http://www.wikidata.org/entity/Q37416404> ?p ?o ?g. }
- Q37416404 description "article científic" @default.
- Q37416404 description "article scientifique" @default.
- Q37416404 description "articolo scientifico" @default.
- Q37416404 description "artigo científico" @default.
- Q37416404 description "artículu científicu espublizáu en 2009" @default.
- Q37416404 description "bilimsel makale" @default.
- Q37416404 description "scientific article published on 17 March 2009" @default.
- Q37416404 description "vedecký článok" @default.
- Q37416404 description "vetenskaplig artikel" @default.
- Q37416404 description "videnskabelig artikel" @default.
- Q37416404 description "vědecký článek" @default.
- Q37416404 description "wetenschappelijk artikel" @default.
- Q37416404 description "wissenschaftlicher Artikel" @default.
- Q37416404 description "наукова стаття, опублікована в березні 2009" @default.
- Q37416404 description "научни чланак" @default.
- Q37416404 description "գիտական հոդված հրատարակված 2009 թվականի մարտի 17-ին" @default.
- Q37416404 description "مقالة علمية نشرت في 17 مارس 2009" @default.
- Q37416404 name "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 name "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 name "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 type Item @default.
- Q37416404 label "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 label "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 label "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 prefLabel "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 prefLabel "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 prefLabel "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 P1433 Q37416404-443A6B9B-A83C-4411-A078-90E27A24E62A @default.
- Q37416404 P1476 Q37416404-3CB9133F-B26B-43B4-86C1-AE041EEC60E4 @default.
- Q37416404 P2093 Q37416404-07DD9AF2-7BBD-4270-ACD8-0D4C368B3BAC @default.
- Q37416404 P2093 Q37416404-33336608-6D4B-4B7D-96ED-6D72A940146A @default.
- Q37416404 P2093 Q37416404-77797657-9C37-43D0-8CE7-C8D1478D6729 @default.
- Q37416404 P2093 Q37416404-EE5797FC-4162-4EB0-B330-7A564B90F113 @default.
- Q37416404 P2860 Q37416404-20373D91-F184-42AC-B6C5-C07301518687 @default.
- Q37416404 P2860 Q37416404-3EB39FD1-6610-4B08-8017-015FA669C99A @default.
- Q37416404 P2860 Q37416404-44AC841A-7348-4E8B-8B3B-7D314E6292EE @default.
- Q37416404 P2860 Q37416404-486EBFD5-E2CF-4C07-9321-CD1421E95DFB @default.
- Q37416404 P2860 Q37416404-52B5AFBE-9FAB-4F28-BDBB-2B859A7A5F0C @default.
- Q37416404 P2860 Q37416404-5767B65D-D26D-452E-A882-C36A17604217 @default.
- Q37416404 P2860 Q37416404-7DEEBD39-9B63-4F6C-8115-403E16D905A5 @default.
- Q37416404 P2860 Q37416404-8CBBD290-93B7-4036-AA1E-ED3CD7E46A86 @default.
- Q37416404 P2860 Q37416404-9A3ED50A-A227-41C0-98AD-CB0BBADC444D @default.
- Q37416404 P2860 Q37416404-AF424A71-C5AA-4FDC-B33D-DC2528A5ED59 @default.
- Q37416404 P2860 Q37416404-CFAA012D-6D20-44D7-A969-B4611C234527 @default.
- Q37416404 P2860 Q37416404-D7D1C328-E198-4D9B-BC1A-BDE0B55116D0 @default.
- Q37416404 P2860 Q37416404-D95C2D29-EF97-44BF-9153-CEA15FC1EF3A @default.
- Q37416404 P2860 Q37416404-DF9A014B-351E-4984-A561-1BEBF4EDE3E5 @default.
- Q37416404 P2860 Q37416404-EDBFEE53-2C34-4E1E-BBDC-5EF9C9E7271E @default.
- Q37416404 P2860 Q37416404-F60D951D-C9F1-4640-AEC5-0698ED1D8418 @default.
- Q37416404 P304 Q37416404-9B36C8BC-EA90-4E38-AE79-30B0047B4F48 @default.
- Q37416404 P31 Q37416404-60946D2A-5F18-4768-839E-D708E99B0DDF @default.
- Q37416404 P356 Q37416404-27D28BEB-2475-4902-BCB4-7E06CA50365C @default.
- Q37416404 P407 Q37416404-97C44C5A-71C8-4029-9A31-9A3520E76089 @default.
- Q37416404 P433 Q37416404-58CD9E9D-8A95-46A2-85BC-DB00E61A9582 @default.
- Q37416404 P478 Q37416404-977BB7E6-DBA5-45AC-ABA7-A71DCC602E45 @default.
- Q37416404 P577 Q37416404-E2433AB5-0040-4D50-90E5-73AC6F079737 @default.
- Q37416404 P698 Q37416404-526EB8BD-5C2C-4837-A87B-0239EB3AFE1B @default.
- Q37416404 P921 Q37416404-1440E663-DCFC-4532-B89D-796A895EEA50 @default.
- Q37416404 P921 Q37416404-5F132126-3E8E-4B66-9BF5-7233A0AE6923 @default.
- Q37416404 P921 Q37416404-9D337C0F-4FA7-4980-9FE4-EF5B6FBFECC0 @default.
- Q37416404 P921 Q37416404-9F84C150-D8AA-4A89-89FA-B10A65640A44 @default.
- Q37416404 P921 Q37416404-A8BAB8C2-13B1-4C7D-BBA1-F10197FBABDF @default.
- Q37416404 P921 Q37416404-BD2B0694-6D5D-441A-AC43-8DCF0DE98056 @default.
- Q37416404 P356 S10067-009-1149-4 @default.
- Q37416404 P698 19291350 @default.
- Q37416404 P1433 Q15754927 @default.
- Q37416404 P1476 "Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients" @default.
- Q37416404 P2093 "Primal P Kaur" @default.
- Q37416404 P2093 "Sophia Li" @default.
- Q37416404 P2093 "Steven Berney" @default.
- Q37416404 P2093 "Virginia Chan" @default.
- Q37416404 P2860 Q27480421 @default.
- Q37416404 P2860 Q34173680 @default.
- Q37416404 P2860 Q35552129 @default.
- Q37416404 P2860 Q35579382 @default.
- Q37416404 P2860 Q35777601 @default.
- Q37416404 P2860 Q37067835 @default.
- Q37416404 P2860 Q40977680 @default.
- Q37416404 P2860 Q43030737 @default.
- Q37416404 P2860 Q43580784 @default.
- Q37416404 P2860 Q43635427 @default.
- Q37416404 P2860 Q45722615 @default.
- Q37416404 P2860 Q55047291 @default.
- Q37416404 P2860 Q74002465 @default.
- Q37416404 P2860 Q74586915 @default.
- Q37416404 P2860 Q80129386 @default.
- Q37416404 P2860 Q83127762 @default.
- Q37416404 P304 "787-791" @default.
- Q37416404 P31 Q13442814 @default.
- Q37416404 P356 "10.1007/S10067-009-1149-4" @default.
- Q37416404 P407 Q1860 @default.
- Q37416404 P433 "7" @default.
- Q37416404 P478 "28" @default.
- Q37416404 P577 "2009-03-17T00:00:00Z" @default.
- Q37416404 P698 "19291350" @default.
- Q37416404 P921 Q154869 @default.
- Q37416404 P921 Q18032037 @default.
- Q37416404 P921 Q181600 @default.
- Q37416404 P921 Q187255 @default.
- Q37416404 P921 Q348260 @default.